Life after COVID: disease management and diagnostics in the post-pandemic era (RED 2021)

Life after COVID: disease management and diagnostics in the post-pandemic era (RED 2021)

For the past two years, healthcare systems everywhere were preoccupied with COVID-19 management, but as we gradually recalibrate to a new normal, questions arise about what the future will hold. What is the role of hospitals and clinical labs in a world where COVID-19 is endemic? How will we simultaneously meet the growing challenges of both infectious and chronic diseases? And what is the role of digital technology and new remote models of care in a tech-driven future?

In the opening at RED 2021, an annual thought-leadership conference hosted by Roche Diagnostics Asia Pacific, Prof Teo Yik Ying, Dean of the Saw Swee Hock School of Public Health at the National University of Singapore, moderated a wide-ranging conversation on these important questions with a regional panel of experts from the clinical lab, hospital management and digital health communities. The panelists included:

  • Dr Chris Douglas, Medical Director, Histopath Diagnostic Specialists, Australia
  • Mr Anand K, CEO, SRL Diagnostics, India
  • Dr Harish Pillai, CEO, Metro Pacific Hospital Holdings, Philippines
  • Mr Anand Swaminathan, Senior Partner – Leader of McKinsey Digital (Asia), McKinsey & Company, Singapore
  • Prof Teo Yik Ying, Dean, Saw Swee Hock School of Public Health, National University of Singapore, Singapore

Watch the full video at the link below.

Lainnya dalam topik yang sama

Rekomendasi topik

SequencingRED 2020Rare Diseases
Bacaan Berikutnya
Scroll to Top